CYCLONE 2: A phase 3 study of abemaciclib with abiraterone in patients with metastatic castration-resistant prostate cancer

被引：0
|
作者：
Smith, Matthew Raymond
Piulats, Josep M.
Todenhofer, Tilman
Lee, Jae-Lyun
Arija, Jose Angel Arranz
Mazilu, Laura
Azad, Arun
Alonso-Gordoa, Teresa
McGovern, Ursula Brigid
Choudhury, Atish Dipankar
Ye, Dingwei
Suzuki, Hiroyoshi
Mckay, Rana R.
Ades, Steven
Flechon, Aude
Pieczonka, Christopher Michael
Hulstijn, Maarten
Lithio, Andrew
Nacerddine, Karim
Agarwal, Neeraj
机构：
[1] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[2] Inst Catal Oncol Bellvitge Inst Biomed Res, Barcelona, Spain
[3] Studienpraxis Urol, Nurtingen, Germany
[4] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
[5] Hosp Univ Gregorio Maranon, Madrid, Spain
[6] Clin Emergency Hosp, Constanta, Romania
[7] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[8] Hosp Univ Ramon y Cajal, Med Oncol Dept, Madrid, Spain
[9] Univ Coll Hosp London, London, England
[10] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[11] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[12] Toho Univ, Sakura Med Ctr, Chiba, Japan
[13] Univ Calif San Diego, La Jolla, CA USA
[14] Univ Vermont, Larner Coll Med, Burlington, VT USA
[15] Ctr Leon Berard, Lyon, France
[16] Associated Med Professionals NY, Syracuse, NY USA
[17] Eli Lilly & Co, Indianapolis, IN USA
[18] Huntsman Canc Inst, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5001
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I study of capivasertib in combination with abiraterone acetate in patients with metastatic castration-resistant prostate cancer.
    Shore, Neal D.
    Mellado, Begona
    Shah, Satish
    Hauke, Ralph J.
    Costin, Dan
    Morris, Thomas
    Anjum, Rana
    Szijgyarto, Zsolt
    Verheijen, Remy B.
    Cullberg, Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [22] A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1
    Agarwal, Neeraj
    Castellano, Daniel
    Alonso-Gordoa, Teresa
    Arija, Jose Angel Arranz
    Colomba, Emeline
    Gravis, Gwenaelle
    Mourey, Loic
    Oudard, Stephane
    Flechon, Aude
    Gonzalez, Macarena
    Rey, Pablo M.
    Schweizer, Michael T.
    Gallardo, Enrique
    Johnston, Erica
    Balar, Arjun
    Haddad, Nadine
    Appiah, Adams K.
    Nacerddine, Karim
    Piulats, Jose M.
    CLINICAL CANCER RESEARCH, 2024, 30 (11) : 2377 - 2383
  • [23] Randomized phase II trial of abiraterone ± dasatinib for patients with metastatic castration-resistant prostate cancer (mCRPC).
    Dorff, Tanya B.
    Quinn, David I.
    Pinski, Jacek K.
    Goldkorn, Amir
    Sadeghi, Sarmad
    Tsao-Wei, Denice
    Groshen, Susan G.
    Kuhn, Peter
    Gross, Mitchell E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [24] Abiraterone experience in a patient with metastatic castration-resistant prostate cancer on hemodialysis
    Eryilmaz, Melek Karakurt
    Karaagac, Mustafa
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 2031 - 2034
  • [25] Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
    Efstathiou, Eleni
    Titus, Mark
    Wen, Sijin
    Troncoso, Patricia
    Hoang, Anh
    Corn, Paul
    Prokhorova, Ina
    Araujo, John
    Dmuchowski, Carl
    Melhem-Bertrandt, Amal
    Patil, Shiva
    Logothetis, Christopher J.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 119 - 127
  • [26] A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer
    Clayton, Ravinder
    Wu, Jackson
    Heng, Daniel Y.
    North, Scott A.
    Emmenegger, Urban
    Hotte, Sebastien
    Chi, Kim
    Zielinski, Rob
    Al-Shamsi, Humaid
    Chen, Leo
    Eigl, Bernhard
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (9-10): : E583 - E590
  • [27] Clinical use of abiraterone in the treatment of metastatic castration-resistant prostate cancer
    Zobniw, Chrystia M.
    Causebrook, Alanna
    Fong, Mei Ka
    RESEARCH AND REPORTS IN UROLOGY, 2014, 6 : 97 - 105
  • [28] Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer
    Auchus, Richard J.
    Yu, Margaret K.
    Nguyen, Suzanne
    Mundle, Suneel D.
    ONCOLOGIST, 2014, 19 (12): : 1231 - 1240
  • [29] Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer
    Banna, Giuseppe L.
    Urzia, Valeria
    Benanti, Chiara
    Pitre, Alessandra
    Lipari, Helga
    Di Quattro, Rosario
    De Giorgi, Ugo
    Schepisi, Giuseppe
    Basso, Umberto
    Bimbatti, Davide
    Rundo, Francesco
    Libra, Massimo
    Malatino, Lorenzo
    SUPPORTIVE CARE IN CANCER, 2020, 28 (10) : 4687 - 4695
  • [30] Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer
    Giuseppe L. Banna
    Valeria Urzia
    Chiara Benanti
    Alessandra Pitrè
    Helga Lipari
    Rosario Di Quattro
    Ugo De Giorgi
    Giuseppe Schepisi
    Umberto Basso
    Davide Bimbatti
    Francesco Rundo
    Massimo Libra
    Lorenzo Malatino
    Supportive Care in Cancer, 2020, 28 : 4687 - 4695
12345